Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes
NCT00231192
·
clinicaltrials.gov ↗
NA
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Unable to recruit any subjects
Conditions
Diabetes
Interventions
DRUG:
Repaglinide and Insulin
Sponsor
Children's Hospital of Philadelphia